Why the study?
East Asians have a lower risk of ischemic heart disease and higher bleeding risk with antithrombotic medications compared to White Caucasians, but the underlying mechanisms remain incompletely understood.
Do East Asian patients with acute coronary syndrome have different thrombotic profiles and cardiovascular outcomes compared to White patients?
Do East Asian patients with acute coronary syndrome have different thrombotic profiles and cardiovascular outcomes compared to White patients?
East Asian patients with myocardial infarction exhibit a less prothrombotic profile compared to White patients, which correlates with a lower risk of major adverse cardiovascular events.
Answers are grounded in this paper and cite their sources.
Ethnic differences in post-MI thrombogenicity may inform antithrombotic dosing; leaves open prospective validation before practice change.
Background East Asians (EAs), compared to white Caucasians (W), have a lower risk of ischemic heart disease and a higher risk of bleeding with antithrombotic medications. The underlying mechanisms are incompletely understood. Objectives We sought to compare thrombotic profiles of EA and W patients with myocardial infarction (MI) and relate these to cardiovascular outcomes. Methods In a prospective study in the United Kingdom and Korea, blood samples from patients (n = 515) with ST- or non-ST-elevation MI (STEMI and NSTEMI) were assessed using the Global Thrombosis Test, measuring thrombotic occlusion (OT) and endogenous fibrinolysis (lysis time [LT]). Patients were followed for 1 year for major adverse cardiovascular events (MACE) and bleeding. Results EA patients showed reduced OT (longer OT) compared to W (646 seconds [470–818] vs. 436 seconds [320–580], p < 0.001), with similar LT. In STEMI, OT (588 seconds [440–759] vs. 361 seconds [274–462], p < 0.001) and LT (1,854 seconds [1,389–2,729] vs. 1,338 seconds [1,104–1,788], p < 0.001) were longer in EA than W. In NSTEMI, OT was longer (OT: 734 seconds [541–866] vs. 580 seconds [474–712], p < 0.001) and LT shorter (1519 seconds [1,058–2,508] vs. 1,898 seconds [1,614–2,806], p = 0.004) in EA than W patients. MACE was more frequent in W than EA (6.3 vs. 1.9%, p = 0.014) and bleeding infrequent. While OT was unrelated, LT was a strong independent predictor of MACE event after adjustment for risk factors (hazard ratio: 3.70, 95% confidence interval: 1.43–9.57, p = 0.007), predominantly in W patients, and more so in STEMI than NSTEMI patients. Conclusion EA patients exhibit different global thrombotic profiles to W, associated with a lower rate of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Suh et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: